Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Shuichi YONEDA"'
Autor:
Yu Kataoka, Satoshi Kitahara, Sayaka Funabashi, Hisashi Makino, Masaki Matsubara, Miki Matsuo, Yoko Omura-Ohata, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Tsutomu Tomita, Kyoko Honda-Kohmo, Michio Noguchi, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kiminori Hosoda, Stephen J. Nicholls, Satoshi Yasuda, Teruo Noguchi
Publikováno v:
Atherosclerosis Plus, Vol 56, Iss , Pp 1-6 (2024)
Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs modulate diabet
Externí odkaz:
https://doaj.org/article/409a421a06d648bab589ebcb9fd6fd88
Autor:
Teruo Noguchi, Hideki Ota, Naoya Matsumoto, Yoshiaki Morita, Akira Oshita, Eiji Kawasaki, Tomohiro Kawasaki, Kensuke Moriwaki, Shingo Kato, Kazuki Fukui, Tomoya Hoshi, Hiroaki Watabe, Tomoaki Kanaya, Yasuhide Asaumi, Yu Kataoka, Fumiyuki Otsuka, Kensuke Takagi, Shuichi Yoneda, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Hiroyuki Miura, Kunihiro Nishimura, Kei Takase
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Although screening for coronary artery disease (CAD) using computed tomography coronary angiography in patients with stable chest pain has been reported to be beneficial, patients with chronic kidney disease (CKD) might have limit
Externí odkaz:
https://doaj.org/article/23f8a512e04b4914be955bf4309a4ea1
Autor:
Toshiaki Suzuki, Yu Kataoka, Masayuki Shiozawa, Kensuke Morris, Eri Kiyoshige, Kunihiro Nishimura, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Masatoshi Koga, Masafumi Ihara, Kazunori Toyoda, Kenichi Tsujita, Teruo Noguchi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 2 (2023)
Background Acute myocardial infarction (AMI) infrequently occurs after acute stroke. The Heart‐brain team approach has a potential to appropriately manage this poststroke cardiovascular complication. However, clinical outcomes of AMI complicating a
Externí odkaz:
https://doaj.org/article/e8dd324804a642f48cf29b818bd9cc7a
Publikováno v:
Case Reports in Cardiology, Vol 2022 (2022)
It is sometimes difficult to identify the culprit lesion and treatment strategy in patients with acute coronary syndrome who have complex coronary lesions and jeopardized left internal mammary artery graft. This report describes a heart team approach
Externí odkaz:
https://doaj.org/article/6a4317d8a1574ad38361bcb664cc536e
Autor:
Soichiro Abe, Kanta Tanaka, Hiroshi Yamagami, Kazutaka Sonoda, Hiroya Hayashi, Shuichi Yoneda, Kazunori Toyoda, Masatoshi Koga
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Simultaneous cerebral and myocardial infarction is called cardiocerebral infarction (CCI), and is rarely encountered. Because of the narrow time window and complex pathophysiology, CCI is challenging to immediately diagnose and tr
Externí odkaz:
https://doaj.org/article/a26d32dd7bc84a649aa4e701dc4fe2db
Autor:
Kazuhiro Nakao, Teruo Noguchi, Yasuhide Asaumi, Yoshiaki Morita, Tomoaki Kanaya, Masashi Fujino, Hayato Hosoda, Shuichi Yoneda, Shoji Kawakami, Toshiyuki Nagai, Kensaku Nishihira, Takahiro Nakashima, Reon Kumasaka, Tetsuo Arakawa, Fumiyuki Otsuka, Michio Nakanishi, Yu Kataoka, Yoshio Tahara, Yoichi Goto, Haruko Yamamoto, Toshimitsu Hamasaki, Satoshi Yasuda
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Despite the success of HMG-CoA reductase inhibitor (statin) therapy in reducing atherosclerotic cardiovascular events, a residual risk for cardiovascular events in patients with coronary artery disease (CAD) remains. Long-chain n-
Externí odkaz:
https://doaj.org/article/f6610abe624140a3af2170be07b7533c
Autor:
Kota Murai, Yu Kataoka, Eri Kiyoshige, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Hiroyuki Miura, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Kazuhiro Nakao, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kunihiro Nishimura, Teruo Noguchi
Publikováno v:
Circulation: Cardiovascular Interventions; Sep2024, Vol. 17 Issue 9, p806-816, 11p
Autor:
Toshiaki Suzuki, Masashi Fujino, Kota Murai, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Hiroyuki Miura, Satoshi Honda, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Yu Kataoka, Yoshio Tahara, Soshiro Ogata, Kunihiro Nishimura, Kenichi Tsujita, Teruo Noguchi
Publikováno v:
Journal of Cardiology. 81:373-377
Indwelling urethral catheters (IUCs) are used to measure urine volume, keep patients on bed rest, or keep the groin area clean in patients with acute myocardial infarction (AMI). However, the association between IUC use and in-hospital urinary-relate
Autor:
Kazunori MATSUO, Koshi ASAMI, Makito SHINDO, Hiromitsu ARAKI, Junko KOHARA, Hitoshi TSUKAHARA, Hiro TAKAHASHI, Hideki NAGAI, Takeshi MIZUKI, Kazutoshi YOSHIMURA, Kazuaki KAKIUCHI, Kazuyuki MIZUGUCHI, Shuichi YONEDA, Takuya ARIDOME, Takahiro SAINO, Naoko GUSHI, Kyoki TERUYA, Keisuke NINOMIYA, Yoshihisa ABE
Publikováno v:
ESAKIA. 55:7-10
Autor:
Hiroya Hayashi, Yu Kataoka, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Yasuhiro Izumiya, Daiju Fukuda, Teruo Noguchi
Publikováno v:
Cardiovascular Diagnosis and Therapy. 12:803-814
Active cancer associates with increased cardiovascular and bleeding risks in patients with acute myocardial infarction (AMI). Recent chemotherapeutic agents have improved survival rate which enables to induce inactive status of cancer. However, wheth